MurrayGR. 1891. Note on the treatment of myxoedema by hypodermic injections of an extract of the thyroid gland of sheep. Br Med J, 1606:796–797.
3.
ShaplandBJD. 1893. The treatment of myxoedema by feeding with the thyroid gland of sheep. Br Med J, 1684:738–739.
4.
BaumannE. 1896. Uber das normale Vorkommen von Jod im Thierkorper. Ztschr Phys Chem, 21:319–321.
5.
ChatinA. 1852. Recherche de l'iode dans l'air. les eaux, le sol et les produits alimentaires des Alpes de la France et du Piemont. CR Acad Sci (Paris), 34:51–62.
6.
BaumannE. 1896. Uber das thyrojodin. Münch Med Wschr, 43:309.
7.
KendallEC. 1915. The isolation in crystalline form of the compound containing iodine which occurs in the thyroid gland. J Amer Med Assoc, 64:2042–2043.
8.
HaringtonCR. 1926. Chemistry of thyroxine. I. Isolation of thyroxine from the thyroid gland. Biochem J, 20:293–299.
9.
HaringtonCR, BargerG. 1927. Chemistry of thyroxine. III. Constitution and synthesis of thyroxine. Biochem J, 21:169–183.
10.
HaringtonCR. 1935. The biochemical basis of thyroid function. Lancet, 225:1261–1267.
11.
HaringtonCR. 1944. Thyroxine: its biosynthesis and its immunochemistry. Proc R Soc Lond B, 132:223–238.
12.
TaurogA, ChaikoffIL. 1948. The nature of the circulating hormone. J Biol Chem, 176:639–656.
13.
LaidlawJC. 1949. Nature of the circulating thyroid hormone. Nature, 164:927–928.
14.
TaurogA, ChaikoffIL, TongW. 1950. The nature of plasma iodine as revealed by filter paper partition chromatography. J Biol Chem, 184:990104.
15.
RallJE. 1950. Iodine compounds in the blood and urine of man. J Clin Endo Metab, 10:996–1006.
16.
GrossJ, LeblondCP, FranklinAE, QuastelJH. 1950. Presence of iodinated amino acids in unhydrolyzed thyroid and plasma. Science, 111:605–608.
17.
GrossJ, Pitt-RiversR. 1953. 3:5:3′-triiodothyronine.1. Isolation from thyroid gland and synthesis. Biochem J, 53:645–652.
18.
GrossJ, LeblondCP. 1951. The presence of free iodinated compounds in the thyroid and their passage into the circulation. Endocrinology, 48:714.
19.
GrossJ, Pitt-RiversR. 1951. Unidentified compounds in human plasma in addition to thyroxine and iodide. Lancet, 258:766–767.
20.
GrossJ, Pitt-RiversR. 1952. The identification of 3,5,3′-L-triiodothyronine in human plasma. Lancet, 259:439–441.
21.
RocheJ, LissitskyS, MichelR. 1952. Triiodothyronine as an intermediate product in the transformation of diiodothyronine into thyroxine. CR Hebd Seances Acad Sci, 234:997–998.
22.
RocheJ, LissitskyS, MichelR. 1952. Sur la presence de triiodothyronine dans la thyroglobuline. CR Hebd Seances Acad Sci, 234:1228–1230.
23.
GrossJ, Pitt-RiversR. 1952. Physiological activity of 3,5,3′-triiodothyronine. Lancet, 259:593–594.
Pitt-RiversR, StanburyJB, RappB. 1955. Conversion of thyroxine to 3,5,3′-triiodothyronine in vivo. J Clin Endocrinol Metab, 15:616–620.
26.
LassiterWE, StanburyJB. 1958. The in vivo conversion of thyroxine to 2/5/2′-triiodothyronine. J Clin Endocrinol Metab, 18:903–906.
27.
AlbrightEC, LarsonFC, TustRH. 1954. In vitro conversion of thyroxine to triiodothyronine by kidney slices. Proc Soc Expt Biol Med, 86:137–140.
28.
AlbrightEC, LarsenFC. 1959. Metabolism of L-thyroxine by human tissue slices. J Clin Invest, 38:1899–1903.
29.
AlbrightEC, LardyHA, LarsonFC, TomitaK. 1957. Enzymatic conversion of thyroxine to tetraiodothyroacetic acid and of triiodothyronine to triiodothyroacetic acid. J Biol Chem, 224:387–397.
30.
IngbarSH, GaltonVA. 1963. Thyroid. Ann Rev Physiol, 25:361–380.
31.
BravermanLE, IngbarSH, SterlingK. 1970. Conversion of thyroxine to triiodothyronine in athyreotic human subjects. J Clin Invest, 49:855–864.
32.
SterlingK, BrennerMA, NewmanES. 1970. Conversion of thyroxine to triiodothyronine in normal human subjects. Science, 169:1099–1100.
33.
VisserTJ, Van Der Does-TobéI, DocterR, HennemannG. 1976. Subcellular localization of a rat liver enzyme converting thyroxine into tri-iodothyronine and possible involvement of essential thiol groups. Biochem J, 157:479–482.
34.
OppenheimerJH, KoernerD, SchwartzHL, SurksMI. 1972. Specific nuclear triidothyronine binding sites in rat liver and kidney. J Clin Endocrinol Metab, 35:330–333.
35.
SchadlowAR, SurksMI, SchwartzHL, OppenheimerJH. 1972. Specific triiodothyronine binding sites in the anterior pituitary of the rat. Science, 176:1252–1254.
36.
SamuelsHH, TsaiJS. 1973. Thyroid hormone action in cell culture: demonstration of nuclear receptors in intact cells and isolated nuclei. Proc Natl Acad Sci USA, 12:3488–3494.
37.
OppenheimerJH, SchwartzHL, KoernerD, SurksMI. 1974. Limited binding capacity sites for L-triiodothyronine in rat liver nuclei. Nuclear-cytoplasmic interrelation, binding constants, and cross- reactivity with L-thyroxine. J Clin Invest, 53:768–777.
38.
TataJR. 2012. The road to nuclear receptor of thyroid hormones. Biochim Biophys Acta, 2012Mar17[Epub ahead of print]10.1016/j.bbagen.2012.02.017.
39.
SurksMI, OppenheimerJH. 1977. Concentration of L-thyroxine and L-triiodothyronine specifically bound to nuclear receptors in rat liver and kidney. J Clin Invest, 60:555–562.
40.
OppenheimerJH, SchwartzHL, SurksMI. 1972. Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. J Clin Invest, 51:2493–2497.
41.
SilvaJE, LarsenPR. 1977. Pituitary nuclear 3,5,2′-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science, 198:617–620
